We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+9.75%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$268B
AUM Growth
+$39.7B
Cap. Flow
+$21.8B
Cap. Flow %
8.14%
Top 10 Hldgs %
12.83%
Holding
12,049
New
1,180
Increased
5,215
Reduced
3,564
Closed
1,371

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$850M
2
AAPL icon
Apple
AAPL
+$778M
3
TSLA icon
Tesla
TSLA
+$569M
4
ACWI icon
iShares MSCI ACWI ETF
ACWI
+$351M
5
JNJ icon
Johnson & Johnson
JNJ
+$336M

Sector Composition

Rank Sector Weight
1 Technology 10.83%
2 Healthcare 7.49%
3 Financials 7.15%
4 Consumer Discretionary 4.92%
5 Industrials 4.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NXL icon
9451
Nexalin Technology
NXL
$7.49M
$3.3K ﹤0.01%
4,401
+258
+6% +$395
SMLR
9452
DELISTED
Semler Scientific
SMLR
$3.3K ﹤0.01%
100
-2,174
-96% -$75.4K
GSRMU
9453
DELISTED
GSR II Meteora Acquisition Corp. Unit
GSRMU
$3.3K ﹤0.01%
330
CRBP icon
9454
Corbus Pharmaceuticals
CRBP
$177M
$3.3K ﹤0.01%
999
-418
-29% -$1.61K
PFTAU
9455
DELISTED
Perception Capital Corp. III Unit
PFTAU
$3.3K ﹤0.01%
328
+3
+0.9% +$30
CIF
9456
DELISTED
MFS Intermediate High Income Fund
CIF
$3.29K ﹤0.01%
+1,927
New +$3.4K
CEPU
9457
Central Puerto
CEPU
$2.14B
$3.29K ﹤0.01%
553
-4,199
-88% -$20.7K
FEDM icon
9458
FlexShares ESG & Climate Developed Markets ex-US Core Index Fund
FEDM
$80.1M
$3.28K ﹤0.01%
+78
New +$3.14K
SBET icon
9459
Sharplink Inc
SBET
$1.34B
$3.28K ﹤0.01%
88
-7
-7% -$492
SNOA icon
9460
Sonoma Pharmaceuticals
SNOA
$5.41M
$3.28K ﹤0.01%
146
-129
-47% -$4.59K
ARKOW
9461
DELISTED
ARKO Corp Warrant
ARKOW
$3.28K ﹤0.01%
1,872
-2,033
-52% -$3.83K
FOXO
9462
DELISTED
FOXO TECHNOLOGIES INC A
FOXO
$3.28K ﹤0.01%
+43
New +$5.76K
ENER
9463
DELISTED
Accretion Acquisition Corp
ENER
$3.26K ﹤0.01%
323
+170
+111% +$1.7K
BTAL icon
9464
AGF US Market Neutral Anti-Beta Fund
BTAL
$299M
$3.25K ﹤0.01%
153
-27,960
-99% -$580K
SONN
9465
DELISTED
Sonnet BioTherapeutics
SONN
$3.24K ﹤0.01%
+16
New +$3.5K
CLIR icon
9466
ClearSign Technologies
CLIR
$24.5M
$3.23K ﹤0.01%
599
-1,169
-66% -$8.15K
FTPA
9467
DELISTED
FTAC Parnassus Acquisition Corp. Class A Common Stock
FTPA
$3.22K ﹤0.01%
321
-861
-73% -$8.56K
FTEK icon
9468
Fuel Tech
FTEK
$45.2M
$3.21K ﹤0.01%
2,509
-5,991
-70% -$7.68K
AEI icon
9469
Alset
AEI
$42.4M
$3.21K ﹤0.01%
1,395
-2,550
-65% -$9.93K
BBLG
9470
Bone Biologics
BBLG
$1.77M
$3.21K ﹤0.01%
+11
New +$6.2K
GLS
9471
DELISTED
Gelesis Holdings, Inc.
GLS
$3.2K ﹤0.01%
+11,043
New +$5.29K
RKTA.U
9472
DELISTED
Rocket Internet Growth Opportunities Corp. Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant
RKTA.U
$3.2K ﹤0.01%
318
JWSM.WS
9473
DELISTED
Jaws Mustang Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
JWSM.WS
$3.18K ﹤0.01%
45,428
+38,905
+596% +$3.35K
IQSU icon
9474
IQ Candriam US Large Cap Equity ETF
IQSU
$339M
$3.17K ﹤0.01%
99
-358
-78% -$11.7K
ASTSW
9475
DELISTED
AST SpaceMobile, Inc. Warrant
ASTSW
$3.17K ﹤0.01%
+1,599
New +$3.74K

Similar funds

UBS Group's Q4 2022 Portfolio in Review

As of Q4 2022, UBS Group held 12,049 positions worth $268B, up 17% from $228B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group deployed $21.8B of net new capital in Q4 2022, opening 1,180 new positions and adding to 5,215 existing holdings. Its largest new stake was Avantis US Small Cap Value ETF: 210,571 shares worth $15.7M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 11% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Salesforce, an estimated $372M trimmed.

  • UBS Group's largest Q4 2022 buy was Avantis US Small Cap Value ETF: 210,571 shares worth $15.7M.
  • UBS Group added most to Microsoft in Q4 2022, an estimated $850M increase.
  • UBS Group's biggest Q4 2022 reduction was Salesforce, cutting an estimated $372M.
  • UBS Group fully exited Citrix Systems Inc in Q4 2022, selling an estimated $223M.
  • UBS Group's ten largest holdings make up 13% of its $268B portfolio in Q4 2022.
  • UBS Group opened 1,180 new positions and closed 1,371 in Q4 2022.
  • UBS Group's portfolio value rose 17% quarter-over-quarter to $268B.

Based on UBS Group's 13F filing for Q4 2022, filed 8 Feb 2023.